{"id":20253,"date":"2016-03-29T08:00:11","date_gmt":"2016-03-29T12:00:11","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02\/"},"modified":"2016-03-29T08:00:11","modified_gmt":"2016-03-29T12:00:11","slug":"paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02\/","title":{"rendered":"Paragon BioTeck Receives EN ISO 13485:2012 Certification"},"content":{"rendered":"<p>PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) &#8212; Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company&#8217;s successful implementation of an effective quality management system.<\/p>\n<p> The EN ISO 13485:2012 certification was awarded by the International Organization for Standardization, the world&#8217;s largest developer and publisher of global quality and safety standards. This certification outlines specific requirements to establish and execute a structured quality management system for medical devices across all areas, from development to supply. <\/p>\n<p> &#8220;Achieving this certification is an important milestone for Paragon BioTeck,&#8221; said Lauren M-C Bluett, Director of Quality Assurance. &#8220;We have implemented a robust quality management system that conforms to ISO&#8217;s global standards, demonstrating our commitment to excellence in product and operations through continuous improvement and quality by design.&#8221;<\/p>\n<p> Receipt of this certification paves the way for continued advancement of quality systems that meet world-class standards and maintain a central focus on patient safety and care.<\/p>\n<p> <strong>About Paragon BioTeck, Inc.:<\/strong><br \/> Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck&#8217;s portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. <\/p>\n<p> These products include the Comfortear&#174; Lacrisolve&#8482; 180 Absorbable Punctum Plug, Comfortear&#174; Punctum Plug, EqualEyes&#174; Ocular Lubricant, the preservative-free ilast&#174; range of products and their FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution USP, available in 2.5% and 10%.<\/p>\n<p> For more information about Paragon BioTeck and its products, please visit <a href=\"http:\/\/www.paragonbioteck.com\/\">http:\/\/www.paragonbioteck.com\/<\/a>. <\/p>\n<p> Join the conversation on Facebook ( <a href=\"https:\/\/www.facebook.com\/ParagonBioTeck\/\" rel=\"nofollow\">https:\/\/www.facebook.com\/ParagonBioTeck\/<\/a> ) and Twitter: @ParagonBioTeck. <\/p>\n<p> * LOGO for media: Send2Press.com\/wire\/images\/16-0329-paragonbio-300dpi.jpg<\/p>\n<p> <strong>MEDIA CONTACT:<\/strong><br \/> Michael Elofer<br \/> mike@pascalecommunications.com<br \/> (484) 620-6167<\/p>\n<p>News issued by: Paragon BioTeck, Inc.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.send2press.com\/wire\/images\/16-0329-paragonbio-500x375.jpg\" width=\"500\" height=\"375\" alt=\"Paragon BioTeck, Inc.\"\/><\/p>\n<p><small>Original Image: <a href=\"https:\/\/www.send2press.com\/wire\/images\/16-0329-paragonbio-500x375.jpg\" class=\"autohyperlink\" rel=\"nofollow\">https:\/\/www.send2press.com\/wire\/images\/16-0329-paragonbio-500&#215;375.jpg<\/a><\/small><\/p>\n<p> # # # <\/p>\n<p><small>Original Story ID: 2016-0329-02 (10978) :: paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02<\/small><\/p>\n<p><small>Original Keywords:  Paragon BioTeck, Inc. PORTLAND Oregon PORTLAND, Ore.<\/small><\/p>\n<p><small>Alternate Headline: Pharmaceutical and medical device company, Paragon BioTeck receives EN ISO 13485:2012 Certification<\/small><\/p>\n<p><small><strong>NEWS ARCHIVE NOTE:<\/strong> this archival news content, issued by the news source via Send2Press Newswire, was originally located in the Send2Press&reg; 2004-2015 2.0 news platform and has been permanently converted\/moved (and redirected) into our 3.0 platform. Also note the story &#8220;reads&#8221; counter (bottom of page) does not include any data prior to Oct. 30, 2016. This press release was originally published\/issued: Tue, 29 Mar 2016 08:00:11 +0000<\/p>\n<p><\/small><\/p>\n<p><code><small>Original Shortcode for Story: https:\/\/i.send2press.com\/hKbsw<\/small><\/code><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) &#8212; Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company&#8217;s successful implementation of an effective quality management system.<\/p>\n","protected":false},"author":4650,"featured_media":20254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1,571,61,113,600],"tags":[7033],"class_list":["post-20253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news","category-pharma-news","category-health-medical-news","category-manufacturing-news","category-vision-news","tag-ophthalmic-pharmaceuticals","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":5813,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/20253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/4650"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=20253"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/20253\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/20254"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=20253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=20253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=20253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}